TTNP

Titan Pharmaceuticals

Delisted

TTNP was delisted on the 1st of October, 2025.

17 hedge funds and large institutions have $633K invested in Titan Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
17
Holders Change
Holders Change %
0%
% of All Funds
0.27%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
1
Reduced
2
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Truist Financial
1
Truist Financial
North Carolina
$404K
Renaissance Technologies
2
Renaissance Technologies
New York
$88K +$130 +10 +0.1%
Vanguard Group
3
Vanguard Group
Pennsylvania
$53K
Geode Capital Management
4
Geode Capital Management
Massachusetts
$41.4K
State Street
5
State Street
Massachusetts
$24.8K
Citadel Advisors
6
Citadel Advisors
Florida
$19.2K +$19.2K +1,484 New
TRCT
7
Tower Research Capital (TRC)
New York
$1.02K -$26 -2 -2%
LFA
8
Level Financial Advisors
New York
$638
Group One Trading
9
Group One Trading
Illinois
$214
Bank of America
10
Bank of America
North Carolina
$133
Wells Fargo
11
Wells Fargo
California
$54
Fidelity Investments
12
Fidelity Investments
Massachusetts
$40 -$13 -1 -25%
JPMorgan Chase & Co
13
JPMorgan Chase & Co
New York
$40
BlackRock
14
BlackRock
New York
$39
GWSA
15
Global Wealth Strategies & Associates
Colorado
$26
Osaic Holdings
16
Osaic Holdings
Arizona
$23
Morgan Stanley
17
Morgan Stanley
New York
$10
WIM
18
Westside Investment Management
California
$3 -$3
NFSG
19
Newbridge Financial Services Group
Florida
$1 -$2
CIA
20
Cape Investment Advisory
Georgia
$1 -$1
NRG
21
Nemes Rush Group
Michigan
$1
CSC
22
Caldwell Sutter Capital
California
$1 -$2
DJSG
23
D.J. St. Germain
Massachusetts
$1
UBS Group
24
UBS Group
Switzerland
-$1.27K -76 Closed